Symbolic representation of the statement

 

UPDATE: Statement regarding the detectability of the new coronavirus variant using nal von minden GmbH‘s NADAL® COVID-19 Ag Test as well as the dedicio® COVID-19 Ag plus Test

 

Dear customers,

Variations in the SARS-CoV-2 virus have recently been the focus of the media/scientific community. Virus variants like those from Great Britain (VOC 202012/01, lineage B.1.1.7) and South Africa (501.V2, lineage B.1.351), which were first seen in December 2020, have been known to spread rapidly.

 

These changed viruses display prominent mutations in the spike protein, which is thought to be accompanied by a rise in transmissibility. According to the current situation, it can be presumed that the mutation in the S-protein has no effect on the detectability of the virus using nal von minden GmbH’s antigen rapid tests.

 

Our rapid tests do not utilise the spike protein (S-protein) in their detection of the virus, but instead the nucleocapsid protein (N-protein). According to information from the European Centre for Disease Prevention and Control (ECDC) (1), there is no evidence that the new virus strain VOC 202012/01 has any negative bearing on the results of antigen rapid tests. According to our evaluations, the 501.V2 virus variant also does not possess any changes to the N-protein which would adversely affect its detection.

 

The new strains of coronavirus which have emerged from Great Britain and South Africa can be detected using the nal von minden antigen rapid tests just as a reliably as the original coronavirus SARS-CoV-2 variant.

 

 

 

(1) https://www.ecdc.europa.eu/sites/default/files/documents/COVID-19-risk-related-to-spread-of-new-SARS-CoV-2-variants-EU-EEA.pdf